Navigation Links
WA discovery a key to blood cell development
Date:4/28/2009

A West Australian research team has made the world-first discovery a 'pied piper' molecule within blood cells, called Liar, that leads other molecules into the nucleus of the cell, and could offer a key in treating prostate, breast and colon cancers as well as leukemia.

Uncovered by two research groups at the Western Australian Institute for Medical Research (WAIMR) led by Associate Professor Evan Ingley and Director Professor Peter Klinken, they have also identified the function of a known cellular enzyme, Lyn, as a switch that 'turns on' blood cell development.

The findings are published in the April 16 issue of Blood, the journal of the American Society of Hematology, the world's premier hematology journal.

Associate Professor Ingley said the findings were a leap forward in the understanding of how blood cells develop and divide, which could offer them a key to turning off cancerous cell growth.

"LIAR is like a key, which opens a pathway into the nucleus of a blood cell for a number of other molecules, allowing them to flow in and these molecules are what signal the cell to develop and divide," he said.

"From here, if we could control Liar, the hope is that we could use it to switch off the growth of abnormal, or cancerous, cells.

"Because Liar is present in every blood cell, this knowledge could help treat a huge range of conditions and diseases, but where it has most potential is in cancers of the prostate, breast, colon and blood where activity of the enzyme Lyn is heightened."

The focus of the team's investigations, Lyn has now been identified as an enzyme which modifies proteins that triggers the cell to develop further.

Associate Professor Ingley said in their investigations into blood cell development, Lyn became their main focus.

"We could see Lyn had a big influence on blood cell development, so to understand how it works, we looked at what it interacts with and the effects it has," he said.

"What we then saw was Lyn interacting with Liar, and noticed it also interacted with other molecules that signal the cell to behave a certain way.

"Now we have identified Liar and Lyn and we know what they do, we'll be looking at them more closely to find out how they may have the potential to help treat cancers."


'/>"/>

Contact: Sarah Hayward
sarah@capturemedia.com.au
61-893-889-280
Research Australia
Source:Eurekalert

Related medicine news :

1. Discovery of sugar sensor in intestine could benefit diabetes
2. Discovery suggests location of genes for breast density, a strong risk factor for breast cancer
3. Stem cell research produces a key discovery for Fragile X Syndrome
4. Welch Foundation gives $1.6 million for drug discovery research
5. New discovery leaves blood-doping athletes scratching their heads
6. Chemical Diversity Initiates International Prostrate Cancer Discovery Partnership
7. New discovery leaves blood-doping athletes scratching their heads
8. Discovery of widespread tumor growth gene holds promise for effective anti-cancer treatment
9. Discovery supports theory of Alzheimers disease as form of diabetes
10. Discovery Health CME Explores the Benefits and Risks of Aspirin in Aspirin Therapy: Maximizing the Benefits
11. New discovery may improve treatment of one of the worlds leading causes of blindness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... insurance and financial consultation services to residents in the Sacramento/Folsom region, is initiating ... Chance treatment facility. , The Another Choice Another Chance treatment center in Sacramento ...
(Date:12/7/2016)... ... , ... AlignLife clinics nationwide are giving back to their communities by collecting ... bountiful gifts wrapped tightly under a Christmas Tree. AlignLife hopes to spread the ... , In exchange for generous donations, customers will receive a gift in return. ...
(Date:12/7/2016)... ... ... Sharon Kleyne, host of the nationally syndicated radio program, The Sharon Kleyne ... declared on her radio program in November 2016 the need to educate people about ... leaders in corporate America, they are trying to take advantage of successful algorithms and ...
(Date:12/7/2016)... , ... December 07, 2016 , ... Delete® - Tattoo ... Time For The Holiday Party Season. Save Up To 33% Off Botox® and Juvederm® ... is providing the Phoenix Valley with Delightful Deals on Botox® and Juvederm® ...
(Date:12/7/2016)... Studio City, CA (PRWEB) , ... December 07, 2016 , ... ... number during the holidays and winter seasons. One major study analyzing heart attacks ... January compared to August of a given year. We would all agree of course–no ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... -- Anaplastic Oligoastrocytoma - Pipeline Review, H2 2016 ... and Healthcare disease pipeline guide Anaplastic Oligoastrocytoma – ... the Anaplastic Oligoastrocytoma (Oncology) pipeline landscape. Anaplastic ... two types of cells in the brain, called ... form a mass. These brain cells are known ...
(Date:12/6/2016)... YORK , Dec. 6, 2016  Nearly 30 ... suffer from the epidemic of diabetes. 1 ... have persistently elevated glucose levels (hyperglycemia) and significant glucose variability. ... developing serious complications, including cardiovascular events. If left untreated, ... damage and eye disease or blindness. 3 ...
(Date:12/6/2016)... Dec. 6, 2016  Arcturus Therapeutics, Inc. ("Arcturus" ... announced today that it entered into collaboration with ... for the treatment of NASH and other gastrointestinal ... platform LUNAR™ and UNA Oligomer chemistry. The financial ... long-standing commitment to and expertise in GI disorders, ...
Breaking Medicine Technology: